Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.14, 2001-01, pp. : 1055-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy

By Abarientos Crispin Sperber Kirk Shapiro Deborah L Aronow Wilbert S Chao Chun Peng Ash Julia Y

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 705-714

Informa Healthcare

Access to resources Recommend Favorite

Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

By Horizon Arash A Wallace Daniel J

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 273-278

Informa Healthcare

Access to resources Recommend Favorite

Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 438-453

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa Perl Andras

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Belimumab: In Systemic Lupus Erythematosus

By Burness Celeste B. McCormack Paul L.

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2435-2444

Adis International

Access to resources Recommend Favorite